Paper23386830
Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond.
Davidson D and 3 others. Front Pharmacol, 2013. Cited by 128 papers, by iCite.
Cite this record
ConductScience Library. Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond. Papers, record 23386830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23386830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16926856 | Mechanism of homologous recombination: mediators and helicases take on regulatory functions. | Nat Rev Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16926856 | PubMed |
| 2 | 16822724 | Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. | DNA Repair (Amst) | 2006 | https://conductscience.org/library/papers/16822724 | PubMed |
| 3 | 11356153 | Double-strand-break-induced homologous recombination in mammalian cells. | Biochem Soc Trans | 2001 | https://conductscience.org/library/papers/11356153 | PubMed |
| 4 | 11248557 | DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? | Curr Opin Cell Biol | 2001 | https://conductscience.org/library/papers/11248557 | PubMed |
| 5 | 21450809 | Evidence for a remodelling of DNA-PK upon autophosphorylation from electron microscopy studies. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21450809 | PubMed |
| 6 | 19196673 | Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19196673 | PubMed |
| 7 | 15592499 | The life and death of DNA-PK. | Oncogene | 2005 | https://conductscience.org/library/papers/15592499 | PubMed |
| 8 | 16567133 | DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. | DNA Repair (Amst) | 2006 | https://conductscience.org/library/papers/16567133 | PubMed |
| 9 | 18584027 | Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. | PLoS Genet | 2008 | https://conductscience.org/library/papers/18584027 | PubMed |
| 10 | 22226916 | Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway. | Carcinogenesis | 2012 | https://conductscience.org/library/papers/22226916 | PubMed |
| 11 | 16046194 | DNA-PK is responsible for enhanced phosphorylation of histone H2AX under hypertonic conditions. | DNA Repair (Amst) | 2005 | https://conductscience.org/library/papers/16046194 | PubMed |
| 12 | 17630037 | Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. | Lancet | 2007 | https://conductscience.org/library/papers/17630037 | PubMed |
| 13 | 17438073 | Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. | J Cell Biol | 2007 | https://conductscience.org/library/papers/17438073 | PubMed |
| 14 | 21281966 | Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy. | Leuk Res | 2011 | https://conductscience.org/library/papers/21281966 | PubMed |
| 15 | 20526099 | Optimal delivery of cytotoxic chemotherapy for colon cancer. | Cancer J | 2010 | https://conductscience.org/library/papers/20526099 | PubMed |
| 16 | 16249792 | Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026. | Br J Cancer | 2005 | https://conductscience.org/library/papers/16249792 | PubMed |
| 17 | 23059543 | Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines. | Eur J Med Chem | 2012 | https://conductscience.org/library/papers/23059543 | PubMed |
| 18 | 17999957 | The mechanism of human nonhomologous DNA end joining. | J Biol Chem | 2008 | https://conductscience.org/library/papers/17999957 | PubMed |
| 19 | 21664823 | Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines. | Bioorg Med Chem | 2011 | https://conductscience.org/library/papers/21664823 | PubMed |
| 20 | 8619835 | DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by adriamycin. | Biochem Biophys Res Commun | 1996 | https://conductscience.org/library/papers/8619835 | PubMed |
Cited by88
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41427993 | Multi-scale in-silico modelling to unveil structural requirements for DNA-PK inhibitors as radiosensitizers and MolSHAP based design of novel ligands. | J Comput Aided Mol Des | 2025 | https://conductscience.org/library/papers/41427993 | PubMed |
| 40988715 | Design, synthesis, and structure-activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitors. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40988715 | PubMed |
| 40225587 | Hyperglycemia-induced DNA damage response activates DNA-PK complex to promote endothelial ferroptosis in type 2 diabetic cardiomyopathy. | Theranostics | 2025 | https://conductscience.org/library/papers/40225587 | PubMed |
| 39682697 | Cocaine-Induced DNA-Dependent Protein Kinase Relieves RNAP II Pausing by Promoting TRIM28 Phosphorylation and RNAP II Hyperphosphorylation to Enhance HIV Transcription. | Cells | 2024 | https://conductscience.org/library/papers/39682697 | PubMed |
| 39519361 | Disruption of RNA Splicing Increases Vulnerability of Cells to DNA-PK Inhibitors. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519361 | PubMed |
| 39409907 | Impact of Optimized Ku-DNA Binding Inhibitors on the Cellular and In Vivo DNA Damage Response. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39409907 | PubMed |
| 39044839 | The future of cancer treatment: combining radiotherapy with immunotherapy. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39044839 | PubMed |
| 39044064 | Prognostic and Potential Therapeutic Roles of PRKDC Expression in Lung Cancer. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/39044064 | PubMed |
| 39007759 | Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers. | J Med Chem | 2024 | https://conductscience.org/library/papers/39007759 | PubMed |
| 38599791 | The pivotal role of irradiation-induced apoptosis in the pathogenesis and therapy of medulloblastoma. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/38599791 | PubMed |
| 37901223 | Adjusting the dose of traditional drugs combined with immunotherapy: reshaping the immune microenvironment in lung cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/37901223 | PubMed |
| 37149747 | Chemical inhibition of DNA-PKcs impairs the activation and cytotoxicity of CD4+ helper and CD8+ effector T cells. | Immunol Cell Biol | 2023 | https://conductscience.org/library/papers/37149747 | PubMed |
| 36110898 | A high-throughput 384-well CometChip platform reveals a role for 3-methyladenine in the cellular response to etoposide-induced DNA damage. | NAR Genom Bioinform | 2022 | https://conductscience.org/library/papers/36110898 | PubMed |
| 36106115 | Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36106115 | PubMed |
| 35975201 | Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems. | Bioimpacts | 2022 | https://conductscience.org/library/papers/35975201 | PubMed |
| 35681483 | LINCing Senescence and Nuclear Envelope Changes. | Cells | 2022 | https://conductscience.org/library/papers/35681483 | PubMed |
| 35370138 | Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases. | J Pharmacol Exp Ther | 2022 | https://conductscience.org/library/papers/35370138 | PubMed |
| 35361811 | A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress. | Sci Rep | 2022 | https://conductscience.org/library/papers/35361811 | PubMed |
| 35311116 | New Advances in Targeted Therapy of HER2-Negative Breast Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35311116 | PubMed |
| 35163134 | THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163134 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23386830
GET https://conductscience.org/api/papers/v1/23386830/references?page=2